| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | BEKE-W Repurchases 428,900 Shares for USD2.5 million on Wed | ||
| Do | HKD930.9M Southbound Trading Net Outflow from YOFC | ||
| Do | SHANGHAI FUDAN Expects 9M Profit to Rise Up to 2.48x YoY | ||
| Do | Report Says CATHAY PAC AIR Seeks to Increase Order for Up to 50 Widebody Aircraft | ||
| Do | India's Sep Goods Trade Deficit Widens to USD30.21B, in line | ||
| Do | CSPC PHARMA SYS 6088 Injection Approved for Clinical Trials in China | ||
| Do | Eurozone Aug Industrial Output Falls 0.5% MoM, Down 1.1% YoY; Both Miss Forecasts | ||
| Do | TECHTRONIC-100 Repurchases 88,000 Shares on Thu for HKD11.2623 million | ||
| Do | DATANG ENVIRO Completes Issuance of RMB500 million Super Short-term Commercial Paper | ||
| Do | FOREST CABIN Repurchases 155,100 Shares on Thu for HKD8.88M | ||
| Do | CMSI Recommends Focusing on Defensive Picks Amid AI Narrative Volatility; Upgrades Tencent Music Entertainment Group to Buy | ||
| Do | ICBC Completes Issuance of RMB60 Billion Tier-2 Capital Bonds | ||
| Do | MEITU Repurchases 2.8 Million Shares on Thu for HKD9.88 Million | ||
| Do | HUANENG POWER Completes Issuance of RMB2 Billion Ultra-Short-Term Commercial Paper | ||
| Do | TENCENT Repurchases 240,000 Shares for Approx. HKD100 Million on Thu | ||
| Do | CSPC PHARMA SYS 6062 Receives Clinical Trial Approval in China | ||
| Do | HAIER SMARTHOME Repurchases 1M A Shares on Thu for RMB20.1754M | ||
| Do | STANCHART Repurchases 382,300 Shares for GBP8.09M on Wed | ||
| Do | LI NING Repurchases 1.45M Shares on Thu for HKD18.3951M | ||
| Do | Hong Kong's Total Exports Volume Rises 28.6% YoY in Aug; Imports Volume Up 34.6% | ||
| Do | CG SERVICES Repurchases 500,000 Shares on Thu for HKD2.51 million | ||
| Do | Warrants Account for 1.78% of Full-day Market Turnover | ||
| Do | Spot RMB Closes Up 9 bps at 6.6916 Against USD | ||
| Do | GIGADEVICE Spends RMB40.0343 million on A-Share Buyback on Thu | ||
| Do | Short Selling Turnover $44.2B, or 21.6% of Eligible Securities Turnover at Close |